We found that a fraction of Eμ-TCL1 CLL cells possesses ALDH activity, a phenotype that was specifically abrogated using the ALDH inhibitor DEAB (Supplementary Fig. 3). This evidence concerns the gene LDHA and B-cell chronic lymphocytic leukemia.